{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:33:46Z","timestamp":1760402026305,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Venous thromboembolism (VTE) is a compelling challenge across all phases of cancer care as it may result in treatment delays, impaired quality of life (QoL), and increased mortality [...]<\/jats:p>","DOI":"10.3390\/cancers13071556","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T23:27:25Z","timestamp":1616974045000},"page":"1556","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-8712","authenticated-orcid":false,"given":"Patrizia","family":"Ferroni","sequence":"first","affiliation":[{"name":"Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, 00166 Rome, Italy"},{"name":"InterInstitutional Multisciplinary Biobank (BioBIM), IRCCS San Raffaele Roma, 00166 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella","family":"Guadagni","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, 00166 Rome, Italy"},{"name":"InterInstitutional Multisciplinary Biobank (BioBIM), IRCCS San Raffaele Roma, 00166 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Roselli","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Medical Oncology, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"ref_1","first-page":"6S8","article-title":"Cancer and thrombosis: New insights to an old problem","volume":"45","author":"Leiva","year":"2020","journal-title":"J. Med. Vasc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.27772","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States","volume":"119","author":"Khorana","year":"2013","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/rej.2013.1409","article-title":"Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer","volume":"16","author":"Vergati","year":"2013","journal-title":"Rejuvenation Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3324\/haematol.2012.073338","article-title":"Regional lymph node metastases are a strong risk factor for venous thromboembolism: Results from the Vienna Cancer and Thrombosis Study","volume":"98","author":"Dickmann","year":"2013","journal-title":"Haematologica"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1160\/TH10-05-0277","article-title":"Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"104","author":"Ferrante","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ijc.28104","article-title":"Impact of chemotherapy on activated protein C-dependent thrombin generation\u2014Association with VTE occurrence","volume":"133","author":"Roselli","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/157016110790226660","article-title":"Thromboembolic events in patients treated with anti-angiogenic drugs","volume":"8","author":"Ferroni","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_8","first-page":"CD003407","article-title":"Erythropoietin or darbepoetin for patients with cancer","volume":"3","author":"Bohlius","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: A nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nasser, N., Fox, J., and Agbarya, A. (2020). Potential Mechanisms of Cancer-Related Hypercoagulability. Cancers, 12.","DOI":"10.3390\/cancers12030566"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Leiva, O., Connors, J., and Al-Samkari, H. (2020). Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients. Cancers, 12.","DOI":"10.3390\/cancers12071958"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pizzuti, L., Krasniqi, E., Mandoj, C., Marinelli, D., Sergi, D., Capomolla, E., Paoletti, G., Botti, C., Kayal, R., and Ferranti, F. (2020). Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial. Cancers, 12.","DOI":"10.3390\/cancers12040849"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mulder, F., Bosch, F., and van Es, N. (2020). Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?. Cancers, 12.","DOI":"10.3390\/cancers12020367"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Labianca, A., Bosetti, T., Indini, A., Negrini, G., and Labianca, R. (2020). Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer. Cancers, 12.","DOI":"10.3390\/cancers12082070"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rossel, A., Robert-Ebadi, H., and Marti, C. (2020). Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review. Cancers, 12.","DOI":"10.3390\/cancers12030612"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wojtukiewicz, M., Skalij, P., Tokajuk, P., Politynska, B., Wojtukiewicz, A., Tucker, S., and Honn, K. (2020). Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm. Cancers, 12.","DOI":"10.3390\/cancers12051144"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Farge, D., Bournet, B., Conroy, T., Vicaut, E., Rak, J., Zogoulous, G., Barkun, J., Ouaissi, M., Buscail, L., and Frere, C. (2020). Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented. Cancers, 12.","DOI":"10.3390\/cancers12030618"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fotiou, D., Gavriatopoulou, M., and Terpos, E. (2020). Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools. Cancers, 12.","DOI":"10.3390\/cancers12010191"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hohaus, S., Bartolomei, F., Cuccaro, A., Maiolo, E., Alma, E., D\u2019Al\u00f2, F., Bellesi, S., Rossi, E., and Stefano, V. (2020). Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis. Cancers, 12.","DOI":"10.3390\/cancers12051291"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Riondino, S., Ferroni, P., Del Monte, G., Formica, V., Guadagni, F., and Roselli, M. (2020). Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care. Cancers, 12.","DOI":"10.3390\/cancers12051167"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zabrocka, E., and Sierko, E. (2020). Thromboprophylaxis in the End-of-Life Cancer Care: The Update. Cancers, 12.","DOI":"10.3390\/cancers12030600"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/7\/1556\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:25:29Z","timestamp":1760361929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/7\/1556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cancers13071556"],"URL":"https:\/\/doi.org\/10.3390\/cancers13071556","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}